Cardiovascular Diseases Research in Connecticut
Cardiovascular Diseases Research (93.837) awarded $279 million to recipients in Connecticut in 250 grants from fiscal 2021 to 2025, 1.9% of the program's national total. Yale Univ received the most, $238 million.
- Awarded in Connecticut$279 million
- Awards250
- Share of the program1.9%
- Rank among states19th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 110 | $53.7 million |
| FY 2022 | 121 | $55.6 million |
| FY 2023 | 124 | $52.0 million |
| FY 2024 | 125 | $58.1 million |
| FY 2025 | 122 | $60.0 million |
Recipients in Connecticut
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Yale Univ | Colleges and universities | 205 | $238 million |
| University of Connecticut Health Center | Colleges and universities | 16 | $16.6 million |
| University of Connecticut | Colleges and universities | 15 | $10.4 million |
| Inspired Therapeutics LLC | Small businesses | 1 | $6.1 million |
| Cornovus Pharmaceuticals Inc. | Small businesses | 3 | $3.5 million |
| Perosphere Technologies Inc. | Small businesses | 1 | $2.0 million |
| The John B. Pierce Laboratory, Inc | Nonprofits | 1 | $787,237 |
| Sirona Medical Technologies, Inc. | Small businesses | 1 | $323,230 |
| Panluminate Inc | Small businesses | 1 | $312,148 |
| Oncoarendi Therapeutics LLC | Small businesses | 1 | $307,583 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Connecticut?
$279 million from fiscal 2021 to 2025, across 250 awards. Connecticut ranks 19th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Connecticut?
The largest recipient is Yale Univ, with $238 million in 205 awards. Next are University of Connecticut Health Center and University of Connecticut.
Can organizations in Connecticut apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Connecticut
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Temporary Assistance for Needy Families
- National School Lunch Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- USAID Foreign Assistance for Programs Overseas
- Special Education Grants to States
- Title I Grants to Local Educational Agencies